
Students and their supervisors
This page lists the PhD students of the three currently active cycles:
- XXXV cycle (01.10.2019 - 30.09.2022)
- XXXVI cycle (01.10.2020 - 30.09.2023)
Francesco PIERANTONI
XXXVI Cycle (01.10.2020-30.09.2023)
Research area: Urothelial carcinoma
Supervisor: Dott.ssa Vittorina Zagonel
The aim of my research project is to analyze biomarkers which may be able to predict the efficacy of different therapies on patients affected by urothelial carcinoma of the bladder or upper urinary tract.
Mario Domenico RIZZATO
XXXVI Cycle (01.10.2020 - 30.09.2023)
RESEARCH AREA: Biliary Tract Cancers
SUPERVISOR: Dr. Sara Lonardi
The main aim of my project is to improve the knowledge on the molecular alterations in biliary tract cancers and the research of new prognostic and predictive factors
Sarah SHALABY
XXXVI Cycle (01.10.2020-30.09.2023)
Research area: Hepatocellular Carcinoma
Supervisor: Prof. Patrizia Burra
The aim of the study is to evaluate the prevalence of non-neoplastic portal vein thrombosis, its natural history and prognostic role in a cohort of cirrhotic patients with hepatocellular carcinoma.
Edoardo RUGGERI
XXXV Cycle (01.10.2019-30.09.2022)
Research area: Hematological malignancies
Supervisor: Prof. Monica Facco
My research project concerns the identification of new molecular targets in classical Hodgkin’s Lymphoma. It is focused on the PD-1 / PD-L1 axis and on T lymphocyte immunosuppression in the tumor microenvironment.
Federica MIGLIETTA
XXXVI Cycle (01.10.2020-30.09.2023)
Research area: Biological characterization of breast cancer
Supervisor: Prof.ssa Valentina Guarneri
My research acivity is focused on the biological characterization of breast cancer. In particular, the aim of my PhD is the evaluation of the prognostic and/or predictive role of clinical, pathological and molecular biomarkers.
Alessandro PENNA
XXXVI Cycle (01.10.2020-30.09.2023)
Research area: Adoptive Cell Therapy
Supervisor: Prof. Antonio Rosato
Tumor immunology is my laboratory’s main field. In particular, my PhD research project is focused on the use of novel adoptive cell therapies, specifically CAR-transduced effector lymphocytes, and new therapeutic strategies against solid tumors.
Irene BERTAZZOLO
XXXVI Cycle (01.10.2020-30.09.2023)
Research area: T-cell transformation
Supervisor: Prof. Vincenzo Ciminale
The aim of my PhD project is to identify the critical hubs controlling redox homeostasis and cell death pathways in T-cell acute lymphoblastic leukemia (T-ALL). This knowledge will be essential for the development of novel pharmacological strategies to treat drug-resistant T-ALL
Alessandro DAL MASO
XXXVI Cycle (01.10.2020-30.09.2023)
Research area: Clinical and Translational Oncology
Supervisor: Prof. Valentina Guarneri
The aim of my research project is the study of clinical, biohumoral, pathological and molecular biomarkers of immunotherapy response and toxicity.
Greta SCAPINELLO
XXXVI Cycle (01.10.2020-30.09.2023)
Research area: Hematological malignancies
Supervisor: Prof. Francesco Piazza
The aim of my project is to identify the connections between neoplastic cell metabolism, epigenetic modifications and activation of enzymes, potentially implied in the biogenesis of aggressive lymphoma.
Ada TUSHE
XXXVI Cycle (01.10.2020-30.09.2023)
Research area: Tumor immunology
Supervisor: Prof. Susanna Mandruzzato
The aim of my PhD project is to study the immune suppressive activity exerted by myeloid cells and discover new approaches to revert this suppression in cancer patients.
Annavera VENTURA
XXXV Cycle (01.10.2019-30.09.2022)
Research area: Adoptive Cell Therapy
Supervisor: Prof. Antonio Rosato
The aim of my PhD research project is the characterization of the interactions between adoptively transferred murine Cytokine-Induced-Killer (CIK) cells, , cancer cells and the other immune cell populations within the Tumor Micro-Environment.
Letizia PROCACCIO
XXXV Cycle (01.10.2019-30.09.2022)
Research area: Promising use of liquidbiopsy in pancreatic cancer patients
Supervisor: Prof. Sara Lonardi
The aim of my project is to explore the feasibility and potential clinical utility of the circulating tumoral DNA to inform therapy decision making focusing on the prognostic and predictive role of circulating mutant KRAS genes in the blood and in the urine of patients with pancreatic ductal adenocarcinoma.
Luisa PICCIN
XXXV Cycle (01.10.2019-30.09.2022)
Research area: Cancer Immunotherapy Prognostic and Predictive Factors
Supervisor: Prof. PierFranco Conte
Tutor: Prof. Vanna Chiarion Sileni
My clinical and translational research activity is above all focused on the identification of factors involved in response, longer survival, resistance and toxicity to immunotherapetic strategies in skin cancers (above all Melanoma and Merkel Cell Carcinoma), in order to optimize clinical decisions in this field.
Alice ZARAMELLA
XXXV Cycle (01.10.2019-30.09.2022)
Research area: Gastrointestinal cancers
Supervisor: Prof. Matteo Fassan
The main aim of my project is to explore the gastric and esophageal microbiota in pre-cancerous and cancerous lesions to identify specific bacteria that could plays a role in carcinogenesis
Lorenzo NICOLE'
XXXV Cycle (01.10.2019-30.09.2022)
Research area: Artificial Intelligence in Pathology research
Supervisor: Prof. Angelo Paolo Dei Tos
The aim of my project is to improve the ability to recognize rare cancers histology developing an AI algorithm able to predict specific fusion-gene alterations in small round cell sarcomas analyzing hematoxylin&eosin-stained slides
Stefania PELLEGRINI
XXXV Cycle (01.10.2019-30.09.2022)
Research area: Genetic predisposition to melanoma
Supervisor: Dr. Chiara Menin
The main aim of the project is to study the genetic factors of familial melanoma, also in the wider context of melanoma syndromes and multiple primary melanomas.
Nicole CONTRAN
XXXV Cycle (01.10.2019-30.09.2022)
Research area: Colorectal cancer and pancreatic cancer
Supervisor: Prof. Daniela Basso
The overall aim of my project is to discover new biomarkers for the non-invasive early diagnosis of colorectal cancer and pancreatic cancer and to verify their potential role in cancerogenesis.
Brigida BARBERIO
XXXV Cycle (01.10.2019-30.09.2022)
Research area: Inflammatory Bowel Diseases
Supervisors: Dr Fabiana Zingone, Prof Edoardo Savarino
The aims of my project are:
- to investigate the role of micro-RNA in the development and natural course of colorectal cancer associated to Inflammatory Bowel Diseases (IBD-CRC);
- to identify potantial non-invasive and early biomarkers for IBD-CRC screening, progression, and monitoring.
Antonino Alex CARTALEMI
XXXV Cycle (01.10.2019-30.09.2022)
Research area: Cancer Metabolism
Supervisor: Dr. Giovanni Tonon
The aim of this project is to unravel the metabolic reprogramming caused by the epigenetic deregulation characterizing Multiple Myeloma cells. The metabolic weaknesses will be exploited to test the Myeloma sensitivity to different drugs targeting specific metabolic pathways
Aamir AMIN
XXXIV Cycle (01.10.2018-30.09.2021)
Research area: Extra-telomeric functions of Telomerase (TERT)
Supervisor: Prof. Anita de Rossi
The aim of my project is to study the non-canonical functions of TERT in cellular immortalization and identifying its interaction partners with the goal to unravel the cellular pathways being (de)regulated by reactivated telomerase during oncogenic transformatio
Antonio COLLESEI
XXXVI Cycle (01.10.2020 - 30.09.2023)
Research area: Bioinformatics and Computational Oncology
Supervisors: Dr. Francesca Schiavi, Prof. Fabio Vandin, Dr. Rita Zamarchi
As a Bioengineer, my objective is to tackle increasingly complex datasets by implementing Machine Learning models and statistical tools. My current focus is turned toward understanding tumor heterogeneity and clonality through analysis of germline and somatic variants.